Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free vs Opioid-based Anesthesia in Transsphenoidal Surgery
NCT03120234Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and ketamine in Pituitary carcinoma (PC), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoints: Emergence time at 15 months, Extubation time at 15 months and 1 more. Started Jan 2017; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
Pituitary carcinoma (PC)
Beyond the preview
Go deeper on NCT03120234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120234.